Stocks & Investing
Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 1, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, January 18, 2024
[ 12:00 AM ] - WOPRAI
Tue, November 14, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
Wed, September 6, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 21, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, July 21, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 26, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
Wed, March 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 27, 2022
[ 12:00 AM ] - WOPRAI
Fri, July 29, 2022
Wed, June 29, 2022
[ 12:00 AM ] - WOPRAI
Fri, November 12, 2021
[ 12:00 AM ] - WOPRAI
Tue, November 2, 2021
[ 12:00 AM ] - WOPRAI
Wed, April 28, 2021 Gregory Fraser Downgraded (ANIP) to Hold and Decreased Target to $60 on, Sep 11th, 2024
Gregory Fraser of Truist Securities, Downgraded "ANI Pharmaceuticals, Inc." (ANIP) to Hold and Decreased Target from $80 to $60 on, Sep 11th, 2024.
Gregory has made no other calls on ANIP in the last 4 months.
There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Gregory's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gregory
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $94 on, Wednesday, August 7th, 2024
